schizophrenia

Oct 03 2024

Uncategorized

I Wish I Had Been Taught About Schizophrenia

by Clinical Editor

No Comments

When I thought of “mental illness,” people who I considered to be “weak” immediately came to mind. I didn’t understand why the mentally ill did not just pull themselves

Oct 02 2024

Uncategorized

Clozapine and Respiratory Infection Risk: What to Know – Medscape

by Clinical Editor

No Comments

Clozapine and Respiratory Infection Risk: What to Know  Medscape

Oct 02 2024

Uncategorized

FDA approves 1st new drug for schizophrenia in more than 30 years

by Clinical Editor

No Comments

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.

Oct 01 2024

Uncategorized

Schizophrenia treatment offers alternative with fewer side effects

by Clinical Editor

No Comments

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major advancement in schizophrenia treatment in decades.

Oct 01 2024

Uncategorized

Some Parameters of cTBS Reduce Auditory Hallucinations in Schizophrenia

by Clinical Editor

No Comments

Investigators conducted a systematic review and meta-analysis to elucidate the efficacy and safety of cTBS for the treatment of auditory hallucinations in schizophrenia.

Sep 30 2024

Uncategorized

This FDA-approved drug promises a new way to treat schizophrenia

by Clinical Editor

No Comments

Bristol Myers Squibb’s drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments …

Sep 30 2024

Uncategorized

FDA approves of a new schizophrenia drug

by Clinical Editor

No Comments

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.The drug, generically called Cob …

Sep 29 2024

Uncategorized

FDA approves a novel drug for schizophrenia, a potential ‘game changer’

by Clinical Editor

No Comments

The U.S. Food and Drug Administration late Thursday approved a new kind of drug to treat schizophrenia, a breakthrough after 70 years of incremental innovation that appears to avoid side...

Sep 29 2024

Uncategorized

Medical Minute: Man With Schizophrenia Shares His Journey To Help De-Stigmatize Psychosis

by Clinical Editor

No Comments

Millions of Americans are affected by psychosis, a condition that includes schizophrenia, bipolar disorder, and depression.

Sep 28 2024

Uncategorized

FDA Approves Potentially Groundbreaking Schizophrenia Drug

by Clinical Editor

No Comments

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.